Literature DB >> 30854071

Knockdown of high mobility group box 3 impairs cell viability and colony formation but increases apoptosis in A549 human non-small cell lung cancer cells.

Ning Song1, Baohua Wang2, Guishan Feng3, Lin Duan1, Shengfang Yuan1, Weihua Jia1, Yi Liu1.   

Abstract

Previous research has linked high mobility group box 3 (HMGB3) overexpression to the malignant progression and poor prognosis of non-small cell lung cancer (NSCLC). The present study investigated the role of HMGB3 in cell survival and colony formation of NSCLC cells. Stable knockdown of HMGB3 in A549 cells was achieved by lentiviral-based shRNA interference and verified by detection of the transcriptional and translational level of HMGB3 with reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The influence of HMGB3 knockdown on A549 cell viability and apoptotic rate was evaluated by Cell Counting Kit-8 assay and flow cytometry following annexin V staining, respectively. The proliferative capacity of A549 cells with or without HMGB3 knockdown was compared by measuring their colony forming efficiency. The results of the current study revealed that HMGB3 knockdown significantly reduced cell viability and colony forming efficiency while promoting apoptosis in A549 cells, indicating that HMGB3 may be pivotal for the survival and colony formation of A549 cells, serving a notable role in NSCLC progression.

Entities:  

Keywords:  A549; apoptosis; cell viability; colony forming efficiency; high mobility group box 3; non-small cell lung cancer

Year:  2019        PMID: 30854071      PMCID: PMC6365971          DOI: 10.3892/ol.2019.9927

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  36 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation.

Authors:  Michael J Nemeth; Martha R Kirby; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

3.  Molecular cloning of chick liver HMG 2a cDNA and developmental expression of HMG 2a mRNA.

Authors:  T Oka; Y Endo; M Ito; K Miyamoto; T Sasakawa; I Suzuki; Y Natori
Journal:  Biochim Biophys Acta       Date:  1992-03-24

Review 4.  HMGB proteins: interactions with DNA and chromatin.

Authors:  Michal Stros
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

5.  Clonogenic assay: adherent cells.

Authors:  Haloom Rafehi; Christian Orlowski; George T Georgiadis; Katherine Ververis; Assam El-Osta; Tom C Karagiannis
Journal:  J Vis Exp       Date:  2011-03-13       Impact factor: 1.355

6.  Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation.

Authors:  Michael J Nemeth; David J Curtis; Martha R Kirby; Lisa J Garrett-Beal; Nancy E Seidel; Amanda P Cline; David M Bodine
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

7.  Trends in incidence of small cell lung cancer and all lung cancer.

Authors:  Sharma P Riaz; Margreet Lüchtenborg; Victoria H Coupland; James Spicer; Michael D Peake; Henrik Møller
Journal:  Lung Cancer       Date:  2011-09-03       Impact factor: 5.705

Review 8.  Oncogenes and tumor suppressor genes.

Authors:  Eva Y H P Lee; William J Muller
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-18       Impact factor: 10.005

9.  Hmgb3 deficiency deregulates proliferation and differentiation of common lymphoid and myeloid progenitors.

Authors:  Michael J Nemeth; Amanda P Cline; Stacie M Anderson; Lisa J Garrett-Beal; David M Bodine
Journal:  Blood       Date:  2004-09-09       Impact factor: 22.113

Review 10.  The HMG-box: a versatile protein domain occurring in a wide variety of DNA-binding proteins.

Authors:  M Stros; D Launholt; K D Grasser
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

View more
  11 in total

Review 1.  The role of high mobility group protein B3 (HMGB3) in tumor proliferation and drug resistance.

Authors:  Bin Wen; Ying-Ting Wei; Kui Zhao
Journal:  Mol Cell Biochem       Date:  2021-01-11       Impact factor: 3.396

2.  The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis.

Authors:  Hao-Dong Tang; Yang Wang; Peng Xie; Si-Yuan Tan; Hai-Feng Li; Hao Shen; Zheng Zhang; Zheng-Qing Lei; Jia-Hua Zhou
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

3.  CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis.

Authors:  Yuanyuan Xie; Li Wang; Danfen Yang
Journal:  Cancer Manag Res       Date:  2020-08-04       Impact factor: 3.989

Review 4.  Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy.

Authors:  Anirban Mukherjee; Karen M Vasquez
Journal:  Cancer Res       Date:  2020-03-09       Impact factor: 12.701

5.  Regulation of closely juxtaposed proto-oncogene c-fms and HMGXB3 gene expression by mRNA 3' end polymorphism in breast cancer cells.

Authors:  Ho-Hyung Woo; Setsuko K Chambers
Journal:  RNA       Date:  2021-06-21       Impact factor: 5.636

6.  Hsa_circ_0060937 accelerates non-small cell lung cancer progression via modulating miR-195-5p/HMGB3 pathway.

Authors:  Junfeng Xi; Yunfeng Xi; Zhibin Zhang; Yanhong Hao; Fei Wu; Burong Bian; Guangjun Hao; Weiwei Li; Shuqun Zhang
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

7.  Silencing of Long Non-Coding RNA X Inactive Specific Transcript (Xist) Contributes to Suppression of Bronchopulmonary Dysplasia Induced by Hyperoxia in Newborn Mice via microRNA-101-3p and the transforming growth factor-beta 1 (TGF-β1)/Smad3 Axis.

Authors:  Wenhao Yuan; Xiaoyan Liu; Lingkong Zeng; Hanchu Liu; Baohuan Cai; Yanping Huang; Xuwei Tao; Luxia Mo; Lingxia Zhao; Chunfang Gao
Journal:  Med Sci Monit       Date:  2020-10-18

8.  circHUWE1 Exerts an Oncogenic Role in Inducing DDP-Resistant NSCLC Progression Depending on the Regulation of miR-34a-5p/TNFAIP8.

Authors:  Xueliang Yang; Quan Sun; Yongming Song; Wenli Li
Journal:  Int J Genomics       Date:  2021-12-03       Impact factor: 2.326

9.  Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis.

Authors:  Junli Sun; Keke Xin; Chenghui Leng; Jianlin Ge
Journal:  BMC Pulm Med       Date:  2021-06-06       Impact factor: 3.317

10.  Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis.

Authors:  Bing Xiao; Shi-Gang Lv; Miao-Jing Wu; Xiao-Li Shen; Wei Tu; Min-Hua Ye; Xin-Gen Zhu
Journal:  J Neurooncol       Date:  2021-08-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.